Mark Nachtigal, PhDUniversity of Manitoba Autocrine bone morphogenic protein (BMP) inhibition: a novel therapeutic strategy for ovarian cancer? Protein growth factors belonging to the transforming growth factor beta (TGFβ) superfamily, which include bone morphogenic proteins (BMPs), influence the growth, motility, and invasive potential of ovarian cancer cells. Blocking of these pathways may produce a more […]
Read More